Home News DoD Funds Study For Early COVID-19 Symptom Detection Wearable back to News
minute read
Global health technology leader Royal Philips and continuous health monitoring company BioIntelliSense will receive nearly $2.8 million from the US Department of Defense (DoD) to validate BioIntelliSense’s FDA-cleared BioSticker wearable device for early COVID-19 symptom detection.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
